2023-505012-38-00已完成1 期
A study to test how a new long-acting insulin works in the body of patients with type 2 diabetes during exercise and prolonged fasting.
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
EU Submission Hub
Scientific
Novo Nordisk A/S
研究点 (1)
Loading locations...
相似试验
已完成
不适用
The efficancy of a new long-acting insulin degludec in patient with diabetesdiabetesJPRN-UMIN000011567Osaka Saiseikai Noe Hospital100
进行中（未招募）
1 期
Research study comparing insulin degludec to insulin detemir, together with insulin aspart, in pregnant women with type 1 diabetesDiabetes Mellitus, Type 1MedDRA version: 21.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861EUCTR2017-000048-17-DKovo Nordisk A/S214
进行中（未招募）
1 期
Research study comparing insulin degludec to insulin detemir, together with insulin aspart, in pregnant women with type 1 diabetesMedDRA version: 20.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 1EUCTR2017-000048-17-GRovo Nordisk A/S300
进行中（未招募）
1 期
Research study comparing insulin degludec to insulin detemir, together with insulin aspart, in pregnant women with type 1 diabetesMedDRA version: 21.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 1EUCTR2017-000048-17-ITOVO NORDISK. S.P.A.300
进行中（未招募）
1 期
Research study comparing insulin degludec to insulin detemir, together with insulin aspart, in pregnant women with type 1 diabetesDiabetes Mellitus, Type 1EUCTR2017-000048-17-ATovo Nordisk A/S214